Truecheck Notu: Bugn in GLP-1 Kanser Tedavisi Deildir Bu veriler, GLP-1 reseptr agonistlerinin kanser tedavisi olarak balanmas gerektiini gstermez
Individuals with a personal or family history of Medullary Thyroid Carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) should not use these medications
, where health meets innovation
But due to the various unknowns for what goes into a compounded medication and the variety of production processes, I recommend that people stay with brand-name medication, says Siegel
Experts warn about possible risks, including a lack of effectiveness, unregulated compounded versions, contamination, overdose, and other safety concerns
Hippocampal insulin resistance impairs spatial learning and synaptic plasticity